Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function

被引:155
作者
Dètivaud, L
Nemeth, E
Boudjema, K
Turlin, B
Troadec, MB
Leroyer, P
Ropert, M
Jacquelinet, S
Courselaud, B
Ganz, T
Brissot, P
Loréal, O
机构
[1] INSERM, U522, Rennes, France
[2] Univ Rennes 1, Rennes, France
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA
[4] Univ Hosp Pontchaillou, Dept Visceral Surg, Rennes, France
[5] Univ Hosp Pontchaillou, Dept Pathol, Rennes, France
[6] Univ Hosp Pontchaillou, Lab Gen Biochem & Enzymol, Rennes, France
[7] Univ Hosp Pontchaillou, Liver Dis Dept, Rennes, France
关键词
D O I
10.1182/blood-2004-12-4855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepcidin, a key regulator of iron metabolism, is synthesized by the liver. Hepcidin binds to the iron exporter ferroportin to regulate the release of iron into plasma from macrophages, hepatocytes, and enterocytes. We analyzed liver samples from patients undergoing hepatic surgery for cancer or receiving liver transplants and analyzed correlations between clinical parameters and liver hepcidin mRNA and urinary hepcidin concentrations. Despite the many potential confounding influences, urinary hepcidin concentrations significantly correlated with hepatic hepcidin mRNA concentrations, indicating that hepcidin quantification in urine is a valid approach to evaluate hepcidin expression. Moreover, we found in humans that hepcidin levels correlated with hepatic iron stores and hemoglobin levels and may also be affected by hepatic dysfunction.
引用
收藏
页码:746 / 748
页数:3
相关论文
共 18 条
  • [1] Decreased liver hepcidin expression in the Hfe knockout mouse
    Ahmad, KA
    Ahmann, JR
    Migas, MC
    Waheed, A
    Britton, RS
    Bacon, BR
    Sly, WS
    Fleming, RE
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2002, 29 (03) : 361 - 366
  • [2] BARRY M, 1971, LANCET, V1, P100
  • [3] An algorithm for the grading of activity in chronic hepatitis C
    Bedossa, P
    Poynard, T
    [J]. HEPATOLOGY, 1996, 24 (02) : 289 - 293
  • [4] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [5] C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism
    Courselaud, B
    Pigeon, C
    Inoue, Y
    Inoue, J
    Gonzalez, FJ
    Leroyer, P
    Gilot, D
    Boudjema, K
    Guguen-Guillouzo, C
    Brissott, P
    Loréal, O
    Ilyin, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) : 41163 - 41170
  • [6] Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice
    Courselaud, B
    Troadec, MB
    Fruchon, S
    Ilyin, G
    Borot, N
    Leroyer, P
    Coppin, H
    Brissot, P
    Roth, MP
    Loréal, O
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (02) : 283 - 289
  • [7] Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron
    Gehrke, SG
    Kulaksiz, H
    Herrmann, T
    Riedel, HD
    Bents, K
    Veltkamp, C
    Stremmel, W
    [J]. BLOOD, 2003, 102 (01) : 371 - 376
  • [8] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
    Krause, A
    Neitz, S
    Mägert, HJ
    Schulz, A
    Forssmann, WG
    Schulz-Knappe, P
    Adermann, K
    [J]. FEBS LETTERS, 2000, 480 (2-3) : 147 - 150
  • [9] Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
    Nemeth, E
    Valore, EV
    Territo, M
    Schiller, G
    Lichtenstein, A
    Ganz, T
    [J]. BLOOD, 2003, 101 (07) : 2461 - 2463
  • [10] IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
    Nemeth, E
    Rivera, S
    Gabayan, V
    Keller, C
    Taudorf, S
    Pedersen, BK
    Ganz, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) : 1271 - 1276